FAMILY PLANNING: Edited by Paul D. BlumenthalAbortion through telemedicineFok, Wing Kaya; Mark, AlicebAuthor Information aStanford University, Stanford, California bNational Abortion Federation, Washington, DC, USA Correspondence to Wing Kay Fok, MD, MS, Stanford University, 300 Pasteur Drive HG332, Stanford, CA 94305, USA. Tel: +1 650 724 4683; e-mail: [email protected] Current Opinion in Obstetrics and Gynecology: December 2018 - Volume 30 - Issue 6 - p 394-399 doi: 10.1097/GCO.0000000000000498 Buy Metrics Abstract Purpose of review Medical abortion offers a well tolerated and effective method to terminate early pregnancy, but remains underutilized in the United States. Over the last decade, ‘telemedicine’ has been studied as an option for medical abortion to improve access when patients and providers are not together. A number of studies have explored various practice models and their feasibility as an alternative to in-person service provision. Recent findings A direct-to-clinic model of telemedicine medical abortion has similar efficacy with no increased risk of significant adverse events when compared with in-person abortion. A direct-to-consumer model is currently being studied in the United States. International models of direct-to-consumer medical abortion have shown promising results. Summary The introduction of telemedicine into abortion care has been met with early success. Currently, there are limitations to the reach of telemedicine because of specific restrictions on mifepristone in the United States as well as laws that specifically prohibit telemedicine for abortion. If these barriers are removed, telemedicine can potentially increase abortion access. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.